MENU

 Education

School ¡X Major ¡X Degree Duration

°ª¶¯Âå¾Ç¤j¾Ç ¡X Âå¾Ç°|Âå¾Ç¬ã¨s©Ò(²¦) ¡X ³Õ¤h

Doctorate, Graduate Institute of Medicine,College of Medicine, Kaohsiung Medical University

  ¡X 2020/06

°ª¶¯Âå¾Ç¤j¾Ç ¡X Âå¾Ç¬ã¨s©Ò(²¦) ¡X ºÓ¤h

Master,  ,  

2006/09 ¡X 2009/06

°ª¶¯Âå¾Ç¤j¾Ç ¡X Âå¾Ç¨t(²¦) ¡X ¾Ç¤h

Bachelor,  ,  

1995/09 ¡X 2002/07

 Intramural Experience

Office/Department/Institute Position Duration
¤º¬ì³¡   Visiting Staff   ¡X  
¤º¬ì¾Ç¬ì Department of Internal Medicine   Professor 2025/02/01 ¡X  
¤º¬ì¾Ç¬ì Department of Internal Medicine   Associate Professor 2021/08/01 ¡X 2025/01/31
¤º¬ì¾Ç¬ì Department of Internal Medicine   Assistant Professor 2017/02/01 ¡X 2021/07/31

 Extramural Experience

 

 Discipline

 

 Research & Technology Platform Open to the Outside

 

 Interested Area(s)for Interdisciplinary Research

 

 

 Area(s) of Expertise & Research

 

 

 Publication

NO Publication
1

Downregulated antisense lncRNA contributes to the development of lung adenocarcinoma.
«¸§»¿³, ¯Îªö§Í, ±i¬L¤¸,§d¼e¿C,§d¦tÞ¶, ¿à¨Î¨°, ¨H¤l«Û,¬x¤¯¦t,§õ§µ­s,½²­^©ú*, ³\¶®¬Â - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14¨÷(2´Á):854-868­¶
(IF: 3.6, »â°ì±Æ¦W: 106, »â°ì´Á¥Z¼Æ: 322, »â°ì±Æ¦W: 32.92%)

Downregulated antisense lncRNA contributes to the development of lung adenocarcinoma.
Hung-Hsing Chiang, Chai-Tung Ong, Chao-Yuan Chang, Kuan-Li Wu, Yu-Yuan Wu, Jia-Chen Lai, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ying-Ming Tsai, Ya-Ling Hsu - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(2):854-868
(IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%)

2

Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma.
½²­^©ú, §d¼e¿C,¶À¥ÃÄQ Yu-Yuan Wu, Chao-Yuan Chang, ±i¥Ã¸Î, «¸§»¿³, ¼B§D¨q, ¬x¤¯¦t* - - 1 - MOLECULAR MEDICINE REPORTS - MOLECULAR MEDICINE REPORTS 2024 29¨÷(1´Á):9­¶
(IF: 3.4, »â°ì±Æ¦W: 76, »â°ì´Á¥Z¼Æ: 189, »â°ì±Æ¦W: 40.21%)

Upregulated enhancer of rudimentary homolog promotes epithelial‑mesenchymal transition and cancer cell migration in lung adenocarcinoma.
Ying-Ming Tsai, Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Jen-Yu Hung* - - 1 - MOLECULAR MEDICINE REPORTS - MOLECULAR MEDICINE REPORTS 2024;29(1):9
(IF: 3.4, Journal Ranking: 76, Number of Journals of this Field: 189, Ranking: 40.21%)

3

PROM2¤W½Õ¦bªÍÅ쪬²Ó­MÀù¤¤«P¶iÀù²Ó­M²¾¦æ¨Ã¾É­P¤£¨}¹w«á
§d¼e¿C,±i¬L¤¸,½²­^©ú,¿à¨Î¨°,¬x¤¯¦t,ªL¨Ì«Å,½²¨ØÂÈ,³\¶®¬Â* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14¨÷(4´Á):1561-1576­¶
(IF: 3.6, »â°ì±Æ¦W: 106, »â°ì´Á¥Z¼Æ: 322, »â°ì±Æ¦W: 32.92%)

PROM2 upregulation promotes cancer cell migration and confers a poor prognosis in lung squamous cell carcinoma.
Kuan-Li Wu, Chao-Yuan Chang, Ying-Ming Tsai, Jia-Chen Lai, Jen-Yu Hung, Yi-Shiuan Lin, Pei-Hsun Tsai, Ya-Ling Hsu - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(4):1561-1576
(IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%)

4

Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing.
À¹¹Å¨¥, ½²­^©ú, ±i¬L¤¸, ½²ÂE°ö, §d¼e¿C, §d¦tÞ¶, Ling-Yu Wu, ²²QªÚ, ½²¯\âÀ, ¯Îªö§Í, Chien-Hui Sun, ³\¶®¬Â* - - 1 - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 2024 20¨÷(14´Á):5531-5547­¶
(IF: 8.2, »â°ì±Æ¦W: 31, »â°ì´Á¥Z¼Æ: 313, »â°ì±Æ¦W: 9.90%)

Reconstruction of the Hepatic Microenvironment and Pathological Changes Underlying Type II Diabetes through Single-Cell RNA Sequencing.
Chia-Yen Dai, Ying-Ming Tsai, Chao-Yuan Chang, Hung-Pei Tsai, Kuan-Li Wu, Yu-Yuan Wu, Ling-Yu Wu, Shu-Fang Jian, Pei-Hsun Tsai, Chai-Tung Ong, Chien-Hui Sun, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES - INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES 2024;20(14):5531-5547
(IF: 8.2, Journal Ranking: 31, Number of Journals of this Field: 313, Ranking: 9.90%)

5

Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma.
«¸§»¿³, §d¼e¿C, ½²ÂE°ö, ¯Îªö§Í, ±i¬L¤¸, §d¦tÞ¶, ¨H¤l®Ë, ¬x¤¯¦t, §õ§µ­s, ³\¶®¬Â, ½²­^©ú* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024 14¨÷(10´Á):4817-4829­¶
(IF: 3.6, »â°ì±Æ¦W: 106, »â°ì´Á¥Z¼Æ: 322, »â°ì±Æ¦W: 32.92%)

Comprehensive analysis of the oncogenic potential of eukaryotic initiation factor 3M via SAAL1 interaction in lung adenocarcinoma.
Hung-Hsing Chiang, Kuan-Li Wu, Hung-Pei Tsai, Chai-Tung Ong, Chao-Yuan Chang, Yu-Yuan Wu, Tzu-Yen Shen, Jen-Yu Hung, Hsiao-Chen Lee, Ya-Ling Hsu, Ying-Ming Tsai* - - 1 - AMERICAN JOURNAL OF CANCER RESEARCH - AMERICAN JOURNAL OF CANCER RESEARCH 2024;14(10):4817-4829
(IF: 3.6, Journal Ranking: 106, Number of Journals of this Field: 322, Ranking: 32.92%)

6

LAD1³z¹L«P¶iªÍ¸¢Àù¼W¥Í©M¼W¥[«Iŧ©ÊÁYµuªÍÀù±wªÌ¦s¬¡
±i¬L¤¸, ¶À¥ÃµX, «¸§»¿³, §d¦tÞ¶, §d¼e¿C, ±i¥Ã¸Î, ¼B§DÖq, ½²­^©ú*, ³\¶®¬Â - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023 24¨÷(1´Á):431­¶
(IF: 5.6, »â°ì±Æ¦W: 66, »â°ì´Á¥Z¼Æ: 285, »â°ì±Æ¦W: 23.16%)

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma
Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023;24(1):431
(IF: 5.6, Journal Ranking: 66, Number of Journals of this Field: 285, Ranking: 23.16%)

7

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.
³¢®a¦ö, ½²©ú¾§, ¬x¤¯¦t, §d¼e¿C, ½²­^©ú, ½²·¶¯u, ²ø¬Fµq, §õ©§®Ì, ³¯·×ÄQ, ·¨§Ó¤¯*, Áé¶¼¤å* - - 1 - CANCERS - CANCERS 2023 15¨÷(1´Á):187­¶
(IF: 5.2, »â°ì±Æ¦W: 72, »â°ì´Á¥Z¼Æ: 241, »â°ì±Æ¦W: 29.88%)

Different Tyrosine Kinase Inhibitors Used in Treating EGFR-Mutant Pulmonary Adenocarcinoma with Brain Metastasis and Intracranial Intervention Have No Impact on Clinical Outcomes.
Chia-Yu Kuo, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yu-Chen Tsai, Cheng-Hao Chuang, Tai-Huang Lee, Huang-Chi Chen, Chih-Jen Yang, Inn-Wen Chong - - 1 - CANCERS - CANCERS 2023;15(1):187
(IF: 5.2, Journal Ranking: 72, Number of Journals of this Field: 241, Ranking: 29.88%)

8

LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis.
§d¼e¿C,½²­^©ú,¶À¥ÃµX,§d¦tÞ¶,±i¬L¤¸,¼B¤SÞ³,³\¶®¬Â,¬x¤¯¦t* - - 1 - THORACIC CANCER - THORACIC CANCER 2023 14¨÷(4´Á):407-418­¶
(IF: 2.9, »â°ì±Æ¦W: 43, »â°ì´Á¥Z¼Æ: 66, »â°ì±Æ¦W: 65.15%)

LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis.
Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yu-Wei Liu, Ya-Ling Hsu, Jen-Yu Hung - - 1 - THORACIC CANCER - THORACIC CANCER 2023;14(4):407-418
(IF: 2.9, Journal Ranking: 43, Number of Journals of this Field: 66, Ranking: 65.15%)

9

§Q¥Î³æ²Ó­M©w§Ç§Þ³N¯S¼x¤Æ¦Ø½¤·LÀô¹Ò
§d¦tÞ¶, ³\¶®¬Â*, ¶ÀµúµX, Ĭ¬î¤ë, §d¼e¿C, ±i¬L¤¸, ¯Îªö§Í, ¿à¨Î¨°, ¨H¤l®b, ¬x¤¯¦t, ½²­^©ú* - - 1 - THERANOSTICS - THERANOSTICS 2023 13¨÷(13´Á):4412-4429­¶
(IF: 12.4, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 5.88%)

Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer
Wu YY, Hsu YL*, Huang YC, Su YC, Wu KL, Chang CY, Ong CT, Lai JC, Shen TY, Lee TH, Hung JY, Tsai YM* - - 1 - THERANOSTICS - THERANOSTICS 2023;13(13):4412-4429
(IF: 12.4, Journal Ranking: 8, Number of Journals of this Field: 136, Ranking: 5.88%)

10

Involvement of ACACA (acetyl-CoA carboxylase £\) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts
¶ÀµúµX, «J©ú¾W, ½²­^©ú, ¼ïö^¤¤,½²¨ØÂÈ, ªL¨Ì«Å, ±i¬L¤¸,½²­^¬ü, ³\¶®¬Â* - - 1 - Cell Oncol - CELLULAR ONCOLOGY 2023 46¨÷(3´Á):643-660­¶
(IF: 6.6, »â°ì±Æ¦W: 8, »â°ì´Á¥Z¼Æ: 76, »â°ì±Æ¦W: 10.53%)

Involvement of ACACA (acetyl-CoA carboxylase £\) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts
Huang YC, Hou MF, Tsai YM, Pan YC, Tsai PH, Lin YS, Chang CY, Tsai EM, Hsu - - 1 - Cell Oncol - CELLULAR ONCOLOGY 2023;46(3):643-660
(IF: 6.6, Journal Ranking: 8, Number of Journals of this Field: 76, Ranking: 10.53%)

11

Primary pulmonary meningioma.
³\®a»ô, ½²­^©ú, ·¨¾åªÚ, ³\·çª@* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2023 39¨÷(11´Á):1155-1156­¶
(IF: 3.3, »â°ì±Æ¦W: 81, »â°ì´Á¥Z¼Æ: 136, »â°ì±Æ¦W: 59.56%)

Primary pulmonary meningioma.
Chia-Chi Hsu, Ying-Ming Tsai, Sheau-Fang Yang, Jui-Sheng Hsu - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2023;39(11):1155-1156
(IF: 3.3, Journal Ranking: 81, Number of Journals of this Field: 136, Ranking: 59.56%)

12

Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma.
§õ§µ­s, ±i¬L¤¸#, ¶À¥ÃÄQ, §d¼e¿C, «¸§»¿³, ±i¥Ã¸Î, Lian-Xiu Liu, ¬x¤¯¦t, ³\¶®¬Â, Yu-Yuan Wu, ½²­^©ú* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022 11¨÷(5´Á):760­¶
(IF: 5.168, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 94, »â°ì±Æ¦W: 22.34%)

Downregulated ADAMTS1 Incorporating A2M Contributes to Tumorigenesis and Alters Tumor Immune Microenvironment in Lung Adenocarcinoma.
Hsiao-Chen Lee, Chao-Yuan Chang, Yung-Chi Huang, §d¼e¿C, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022;11(5):760
(IF: 5.168, Journal Ranking: 21, Number of Journals of this Field: 94, Ranking: 22.34%)

13

The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.
§õ§µ­s, ±i¬L¤¸#, §d¼e¿C, «¸§»¿³, ±i¥Ã¸Î, Lian-Xiu Liu, ¶À¥ÃÄQ, ¬x¤¯¦t, ³\¶®¬Â, Yu-Yuan Wu, ½²­^©ú* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2022 12¨÷(6´Á):902­¶
(IF: 3.508, »â°ì±Æ¦W: 41, »â°ì´Á¥Z¼Æ: 109, »â°ì±Æ¦W: 37.61%)

The Therapeutic Potential of ADAMTS8 in Lung Adenocarcinoma without Targetable Therapy.
Hsiao-Chen Lee, Chao-Yuan Chang, Kuan-Li Wu, Hung-Hsing Chiang, Yung-Yun Chang, Lian-Xiu Liu, Yung-Chi Huang, Jen-Yu Hung, Ya-Ling Hsu, Yu-Yuan Wu, Ying-Ming Tsai* - - 1 - JOURNAL OF PERSONALIZED MEDICINE - JOURNAL OF PERSONALIZED MEDICINE 2022;12(6):902
(IF: 3.508, Journal Ranking: 41, Number of Journals of this Field: 109, Ranking: 37.61%)

14

Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming.
§d¼e¿C, ¶À¥ÃÄQ, Yu-Yuan Wu, ±i¬L¤¸, ±i¥Ã¸Î, «¸§»¿³, Lian-Xiu Liu, ½²­^©ú, ¬x¤¯¦t* - - 1 - BIOLOGY - BIOLOGY-BASEL 2022 11¨÷(7´Á):975­¶
(IF: 5.168, »â°ì±Æ¦W: 21, »â°ì´Á¥Z¼Æ: 94, »â°ì±Æ¦W: 22.34%)

Characterization of the Oncogenic Potential of Eukaryotic Initiation Factor 4A1 in Lung Adenocarcinoma via Cell Cycle Regulation and Immune Microenvironment Reprogramming.
Kuan-Li Wu, Yung-Chi Huang, Yu-Yuan Wu, Chao-Yuan Chang, Yung-Yun Chang, Hung-Hsing Chiang, Lian-Xiu Liu, Ying-Ming Tsai, Jen-Yu Hung - - 1 - BIOLOGY - BIOLOGY-BASEL 2022;11(7):975
(IF: 5.168, Journal Ranking: 21, Number of Journals of this Field: 94, Ranking: 22.34%)

15

Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.
³\®¦»ô, §d¼e¿C, ½²­^©ú, §õª´¸©, ½²©ú¾§, ³¢®a¦ö, Yu-Chuan Liu, Fu-Wen Liang, ·¨§Ó¤¯, ¬x¤¯¦t* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022 38¨÷(10´Á):1001-1011­¶
(IF: 2.996, »â°ì±Æ¦W: 97, »â°ì´Á¥Z¼Æ: 139, »â°ì±Æ¦W: 69.78%)

Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.
En-Chi Hsu, Kuan-Li Wu, Ying-Ming Tsai, Mei-Hsuan Lee, Ming-Ju Tsai, Chia-Yu Kuo, Yu-Chuan Liu, Fu-Wen Liang, Chih-Jen Yang, Jen-Yu Hung* - - 1 - THE KAOHSIUNG JOURNAL OF MEDICAL SCIENCES - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2022;38(10):1001-1011
(IF: 2.996, Journal Ranking: 97, Number of Journals of this Field: 139, Ranking: 69.78%)

16

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma.
±i¬L¤¸, Yung-Chi Huang, «¸§»¿³, Yu-Yuan Wu, §d¼e¿C, ±i¥Ã¸Î, ¼B̰¨q, ½²­^©ú*, ³\¶®¬Â - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022 24¨÷(1´Á):431­¶
(IF: 6.208, »â°ì±Æ¦W: 69, »â°ì´Á¥Z¼Æ: 296, »â°ì±Æ¦W: 23.31%)

Ladinin 1 Shortens Survival via Promoting Proliferation and Enhancing Invasiveness in Lung Adenocarcinoma.
Chao-Yuan Chang, Yung-Chi Huang, Hung-Hsing Chiang, Yu-Yuan Wu, Kuan-Li Wu, Yung-Yun Chang, Lian-Xiu Liu, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022;24(1):431
(IF: 6.208, Journal Ranking: 69, Number of Journals of this Field: 296, Ranking: 23.31%)

17

Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma.
ÃC©s½B,§d¼e¿C,¼B¤SÞ³,±i¥Ã¸Î,±i¬L¤¸,¬x¤¯¦t,½²­^©ú*,³\¶®¬Â - - 1 - Biology(Basel) - BIOLOGY-BASEL 2021 10¨÷(5´Á):378­¶
(IF: 5.079, »â°ì±Æ¦W: 16, »â°ì´Á¥Z¼Æ: 93, »â°ì±Æ¦W: 17.20%)

Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
Meng-Chi Yen,Kuan-Li Wu,Yu-Wei Liu,Yung-Yun Chang,Chao-Yuan Chang,Jen-Yu Hung,Ying-Ming Tsai,Ya-Ling Hsu - - 1 - Biology(Basel) - BIOLOGY-BASEL 2021;10(5):378
(IF: 5.079, Journal Ranking: 16, Number of Journals of this Field: 93, Ranking: 17.20%)

18

Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations.
³¯¥H¼ä,½²©ú¾§,§õª´¸©,³¢®a¦ö,¨Hª´¬î,½²­^©ú,³¯·×ÄQ,¬x¤¯¦t,¶À©ú½å,Áé¶¼¤å,·¨§Ó¤¯* - - 1 - BMC cancer - BMC CANCER 2021 21¨÷(1´Á):495­¶
(IF: 4.43, »â°ì±Æ¦W: 109, »â°ì´Á¥Z¼Æ: 242, »â°ì±Æ¦W: 45.04%)

Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations.
Yi-Chieh Chen,Ming-Ju Tsai,Mei-Hsuan Lee,Chia-Yu Kuo,Mei-Chiou Shen,Ying-Ming Tsai,Huang-Chi Chen,Jen-Yu Hung,Ming-Shyan Huang,Inn-Wen Chong,Chih-Jen Yang - - 1 - BMC cancer - BMC CANCER 2021;21(1):495
(IF: 4.43, Journal Ranking: 109, Number of Journals of this Field: 242, Ranking: 45.04%)

19

The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
±i¬L¤¸, §d¼e¿C, ±i¥Ã¸Î, ¼B¤SÞ³, ¶À¥ÃµX, ²²QªÚ, ªL¨Ì«Å, ½²¯\âÀ, ¬x¤¯¦t, ½²­^©ú*, ³\¶®¬Â - - 1 - Journal of Personalized Medicine - JOURNAL OF PERSONALIZED MEDICINE 2021 11¨÷(6´Á):578­¶
(IF: 4.945, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 108, »â°ì±Æ¦W: 13.89%)

The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis
Chao-Yuan Chang, Kuan-Li Wu , Yung-Yun Chang , Yu-Wei Liu, Yung-Chi Huang, Shu-Fang Jian, Yi-Shiuan Lin, Pei-Hsun Tsai, Jen-Yu Hung, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - Journal of Personalized Medicine - JOURNAL OF PERSONALIZED MEDICINE 2021;11(6):578
(IF: 4.945, Journal Ranking: 15, Number of Journals of this Field: 108, Ranking: 13.89%)

20

°ª®ñ®ð¬y¶q¤Uºò«æ¤ä®ðºÞÃè§N­áÀøªk¥i¦w¥þ¥Î©óªvÀøªÍÀù®ðºÞ¤º«I¥Ç³y¦¨¤§¤j¶q¥X¦å
¨Hûß¼y,²ø¬Fµq,½²­^©ú,·¨§Ó¤¯* - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021 37 ahe¨÷(9´Á):833-834­¶
(IF: 2.744, »â°ì±Æ¦W: 93, »â°ì´Á¥Z¼Æ: 140, »â°ì±Æ¦W: 66.43%)

Emergent bronchoscopic cryotherapy may safely cease invasive lung cancer induced massive endobronchial hemorrhaging in patients with high oxygen supply.
Feng-Ching Shen,Cheng-Hao Chuang,Ying-Ming Tsai,Chih-Jen Yang - - 1 - The Kaohsiung journal of medical sciences - KAOHSIUNG JOURNAL OF MEDICAL SCIENCES 2021;37 ahe(9):833-834
(IF: 2.744, Journal Ranking: 93, Number of Journals of this Field: 140, Ranking: 66.43%)

21

Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 T‑cell recruitment to prolong survival in lung cancer.
±i¬L¤¸, §d¼e¿C, ±i¥Ã¸Î, ½²¯\ÂÈ, ¬x¤¯¦t, ±iºû¦w, ²²QªÚ, ¶À¥ÃµX, Áé¶¼¤å, ½²­^©ú*, ³\¶®¬Â - - 1 - ONCOLOGY REPORTS - ONCOLOGY REPORTS 2021 46¨÷(3´Á):203­¶
(IF: 3.906, »â°ì±Æ¦W: 133, »â°ì´Á¥Z¼Æ: 242, »â°ì±Æ¦W: 54.96%)

Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4 T‑cell recruitment to prolong survival in lung cancer.
Chao-Yuan Chang, Kuan-Li Wu, Yung-Yun Chang, Pei-Hsun Tsai, Jen-Yu Hung, Wei-An Chang, Shu-Fang Jian, Yung-Chi Huang, Inn-Wen Chong, Ying-Ming Tsai*, Ya-Ling Hsu - - 1 - ONCOLOGY REPORTS - ONCOLOGY REPORTS 2021;46(3):203
(IF: 3.906, Journal Ranking: 133, Number of Journals of this Field: 242, Ranking: 54.96%)

22

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
§d¼e¿C,³¯ßN§D#,½²­^©ú,§õ©§®Ì,±i¨q¬ü,½²·¶¯u,²ø¬Fµq,±iµúÔÐ,§ù¸Î±d,·¨§Ó¤¯*,¬x¤¯¦t,Áé¶¼¤å* - - 2 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2021 10¨÷(19´Á):4376­¶
(IF: 4.241, »â°ì±Æ¦W: 39, »â°ì´Á¥Z¼Æ: 169, »â°ì±Æ¦W: 23.08%)

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
Kuan-Li Wu, Hsiao-Ling Chen, Ying-Ming Tsai, Tai-Huang Lee, Hsiu-Mei Chang, Yu-Chen Tsai, Cheng-Hao Chuang, Yong-Chieh Chang, Yu-Kang Tu, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong - - 2 - Journal of clinical medicine - JOURNAL OF CLINICAL MEDICINE 2021;10(19):4376
(IF: 4.241, Journal Ranking: 39, Number of Journals of this Field: 169, Ranking: 23.08%)

23

miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells.
±iºû¦w, ½²©ú¾§, ¬x¤¯¦t, §d¼e¿C, ½²­^©ú, ¶À¥ÃµX, ±i¬L¤¸, ½²¯\âÀ, ³\¶®¬Â* - - 1 - CANCERS - CANCERS 2021 13¨÷(24´Á):6252­¶
(IF: 6.639, »â°ì±Æ¦W: 51, »â°ì´Á¥Z¼Æ: 242, »â°ì±Æ¦W: 21.07%)

miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells.
Wei-An Chang, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ying-Ming Tsai, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Ya-Ling Hsu* - - 1 - CANCERS - CANCERS 2021;13(24):6252
(IF: 6.639, Journal Ranking: 51, Number of Journals of this Field: 242, Ranking: 21.07%)

24

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment Notch2-Jagged1 Interaction in Lung Cancer.
½²­^©ú,§d¼e¿C, ¼B¤SÞ³, ¶ÀµúÄQ,±i¬L¤¸, ½²¨ØâÀ,Szi-Hui Liao, ¬x¤¯¦t, ³\¶®¬Â* - - 1 - FRONTIERS IN ONCOLOGY - FRONTIERS IN ONCOLOGY 2021 11¨÷(0´Á):696931­¶
(IF: 6.244, »â°ì±Æ¦W: 62, »â°ì´Á¥Z¼Æ: 242, »â°ì±Æ¦W: 25.62%)

Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment Notch2-Jagged1 Interaction in Lung Cancer.
Ying-Ming Tsai, Kuan-Li Wu, Yu-Wei Liu, Wei-An Chang, Yung-Chi Huang, Chao-Yuan Chang, Pei-Hsun Tsai, Szi-Hui Liao, Jen-Yu Hung, Ya-Ling Hsu - - 1 - FRONTIERS IN ONCOLOGY - FRONTIERS IN ONCOLOGY 2021;11(0):696931
(IF: 6.244, Journal Ranking: 62, Number of Journals of this Field: 242, Ranking: 25.62%)

25

Bone marrow derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer
³\¶®¬Â,¶À©ú½å,¬x¤¯¦t,±iºû¦w,½²­^©ú,¼ïÂ襤,ªL¨Ì«Å,½²ÂE°ö,³¢¬fÅï* - - 1 - Oncogene - ONCOGENE 2020 39¨÷(4´Á):739-753­¶
(IF: 7.971, »â°ì±Æ¦W: 14, »â°ì´Á¥Z¼Æ: 178, »â°ì±Æ¦W: 7.87%)

Bone marrow derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer
Hsu YL, Huang MS, Hung JY, Chang WA, Tsai YM, Pan YC, Lin YS, Tsai HP, Kuo PL*. - - 1 - Oncogene - ONCOGENE 2020;39(4):739-753
(IF: 7.971, Journal Ranking: 14, Number of Journals of this Field: 178, Ranking: 7.87%)

26

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer.
½²­^©ú,§d¼e¿C,±i¥Ã¸Î,¬x¤¯¦t,±iºû¦w,±i¬L¤¸,²²QªÚ,½²¯\ÂÈ,¶À¥ÃµX,Áé¶¼¤å,³\¶®¬Â* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21¨÷(5´Á):E1640­¶
(IF: 4.556, »â°ì±Æ¦W: 74, »â°ì´Á¥Z¼Æ: 297, »â°ì±Æ¦W: 24.92%)

Upregulation of Thr/Tyr kinase Increases the Cancer Progression by Neurotensin and Dihydropyrimidinase-Like 3 in Lung Cancer.
Ying-Ming Tsai , Kuan-Li Wu , Yung-Yun Chang , Jen-Yu Hung , Wei-An Chang , Chao-Yuan Chang , Shu-Fang Jian , Pei-Hsun Tsai , Yung-Chi Huang , Inn-Wen Chong , Ya-Ling Hsu* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(5):E1640
(IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%)

27

Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2£\ Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
½²­^©ú,§d¼e¿C,±i¥Ã¸Î,±iºû¦w,¶À¥ÃµX,²²QªÚ,½²¯\ÂÈ,ªL¨Ì«Å,Áé¶¼¤å,¬x¤¯¦t*,³\¶®¬Â - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020 21¨÷(14´Á):5081­¶
(IF: 4.556, »â°ì±Æ¦W: 74, »â°ì´Á¥Z¼Æ: 297, »â°ì±Æ¦W: 24.92%)

Loss of miR-145-5p Causes Ceruloplasmin Interference with PHD-Iron Axis and HIF-2 alpha Stabilization in Lung Adenocarcinoma-Mediated Angiogenesis
Ying-Ming Tsai,Kuan-Li Wu ,Yung-Yun Chang ,Wei-An Chang ,Yung-Chi Huang ,Shu-Fang Jian ,Pei-Hsun Tsai ,Yi-Shiuan Lin ,Inn-Wen Chong ,Jen-Yu Hung ,* Ya-Ling Hsu - - 1 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020;21(14):5081
(IF: 4.556, Journal Ranking: 74, Number of Journals of this Field: 297, Ranking: 24.92%)

28

NIPPV©ó¬´¥½¨HµÛ¯g¦X¨ÖªÍÀù±wªÌ³N«áªÍ´_­ì·ÓÅ@¸gÅç¤À¨É
ªô¤_ºd,³¯­i¦p*,³¯©ÉµØ,¸­²Qµ×,³\ºÝ®e,½²­^©ú - - 9 - ©I§lªvÀø´Á¥Z - 2019 18¨÷(1´Á):P116-117­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

NIPPV in the Treatment of Post-Operative Pulmonary Rehabilitation Care for
Yu-Jhen Ciou, Hung-Ju Chen*, Yi-Hua Chen, Shu-Jing Ye, Tuan-Jung Hsu, Ying-Ming Tsail - - 9 - ©I§lªvÀø´Á¥Z - 2019;18(1):P116-117
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

29

The Roles of MicroRNA in Lung Cancer
§d¼e¿C,½²­^©ú, ³s±Ò±¬,³¢¬fÅï,¬x¤¯¦t* - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019 20¨÷(7´Á):1611­¶
(IF: 4.183, »â°ì±Æ¦W: 46, »â°ì´Á¥Z¼Æ: 172, »â°ì±Æ¦W: 26.74%)

The Roles of MicroRNA in Lung Cancer
Kuan-Li Wu, Ying-Ming Tsai , Chi-Tun Lien, Po-Lin Kuo,Jen-Yu Hung - - 1 - International Journal of Molecular Sciences - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019;20(7):1611
(IF: 4.183, Journal Ranking: 46, Number of Journals of this Field: 172, Ranking: 26.74%)

30

Differential expression profiles of the transcriptome in bone marrow derived cells in lung cancer revealed by next generation sequencing and bioinformatics
±iºû¦w,½²­^©ú,½²·¶¯u,§d¬F¿o,±i°ê®p,³s±Ò´°,¬x¤¯¦t*,³\¶®¬Â.³¢¬fÅï. - - 1 - Oncology Letters - ONCOLOGY LETTERS 2019 17¨÷(15´Á):4341-4350­¶
(IF: 1.871, »â°ì±Æ¦W: 187, »â°ì´Á¥Z¼Æ: 230, »â°ì±Æ¦W: 81.30%)

Differential expression profiles of the transcriptome in bone marrow derived cells in lung cancer revealed by next generation sequencing and bioinformatics
Chang WA, Tsai YM, Tsai YC, Wu CY, Chang KF, Lien CT, Hung JY*, Hsu YL, Kuo PL. - - 1 - Oncology Letters - ONCOLOGY LETTERS 2019;17(15):4341-4350
(IF: 1.871, Journal Ranking: 187, Number of Journals of this Field: 230, Ranking: 81.30%)

31

Female Asthmatic Patients Have Higher Risk to Develop Gemifloxacin-Associated Skin Rash, Highlighting Unique Delayed Onset Characteristics
§d¬îª´,ÃQ§B¾§,¨H¬R§Ê,±i¦°¨},½²­^©ú,¼ï­i¤è,±iµúÔÐ,­³¤S«C,·¨§Ó¤¯* - - 1 - Antibiotics (Basel) - ANTIBIOTICS-BASEL 2019 8¨÷(3´Á):pii: E134.­¶
(IF: 2.921, »â°ì±Æ¦W: 109, »â°ì´Á¥Z¼Æ: 267, »â°ì±Æ¦W: 40.82%)

Female Asthmatic Patients Have Higher Risk to Develop Gemifloxacin-Associated Skin Rash, Highlighting Unique Delayed Onset Characteristics
Chiou-Mei Wu, Po-Ju Wei, Yu-Ting Shen, Hsu-Liang Chang, Ying-Ming Tsai,Hung-Fang Pan, Yong-Chieh Chang, Yu-Ching Wei, Chih-Jen Yang - - 1 - Antibiotics (Basel) - ANTIBIOTICS-BASEL 2019;8(3):pii: E134.
(IF: 2.921, Journal Ranking: 109, Number of Journals of this Field: 267, Ranking: 40.82%)

32

metformin ¹ï©ó³æ®Ö²y²Ó­M¤Àªc¤§²Ä¤@«¬À°§U«¬T²Ó­M¤Àªc¤§¬ÛÃöÁͤƿE¯À¤§§í¨î
³¯«Û§g, ³¢Îë§», ½²­^©ú,ªL©yÀR,¿½´f±l,³¯¦ÊÂÈ,¬x§Ó¿³* - - 1 - Endocrine Research - ENDOCRINE RESEARCH 2018 9¨÷(1´Á):1-7­¶
(IF: 1.518, »â°ì±Æ¦W: 121, »â°ì´Á¥Z¼Æ: 142, »â°ì±Æ¦W: 85.21%)

Suppressive effects of metformin on T-helper 1-related chemokines expression in the human monocytic leukemia cell line THP-1
Chen YC, Kuo CH, Tsai YM, Lin YC, Hsiao HP, Chen BH, Chen YT, Wang SL, Hung CH* - - 1 - Endocrine Research - ENDOCRINE RESEARCH 2018;9(1):1-7
(IF: 1.518, Journal Ranking: 121, Number of Journals of this Field: 142, Ranking: 85.21%)

33

Der f1 induces pyroptosis in human bronchial epithelia via the NLRP3 inflammasome
½²­^©ú,¦¿°êµØ,¬x¤¯¦t,±iºû¦w,ªL¼zµÓ,Á«T©ú,Áé¶¼¤å*,³\¶®¬Â* - - 1 - International Journal of Molecular Medicine - INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2018 41¨÷(2´Á):757-764­¶
(IF: 2.784, »â°ì±Æ¦W: 65, »â°ì´Á¥Z¼Æ: 133, »â°ì±Æ¦W: 48.87%)

Der f1 induces pyroptosis in human bronchial epithelia via the NLRP3 inflammasome
Tsai YM, Chiang KH, Hung JY, Chang WA, Lin HP, Shieh JM, Chong IW, Hsu YL - - 1 - International Journal of Molecular Medicine - INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 2018;41(2):757-764
(IF: 2.784, Journal Ranking: 65, Number of Journals of this Field: 133, Ranking: 48.87%)

34

Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.
½²©ú¾§,¬x¤¯¦t,§õª´¸©,³¢®a¦ö,½²·¶¯u,½²­^©ú,¼B¤j´¼,·¨§Ó¤¯*,¶À©ú½å,Áé¶¼¤å - - 1 - Cancers - CANCERS 2018 10¨÷(11´Á):E434­¶
(IF: 5.326, »â°ì±Æ¦W: 45, »â°ì´Á¥Z¼Æ: 224, »â°ì±Æ¦W: 20.09%)

Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.
Tsai MJ, Hung JY, Lee MH, Kuo CY, Tsai YC, Tsai , Liu TC, Yang CJ*, Huang MS, Chong IW - - 1 - Cancers - CANCERS 2018;10(11):E434
(IF: 5.326, Journal Ranking: 45, Number of Journals of this Field: 224, Ranking: 20.09%)

35

Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.
³\¶®¬Â,¬x¤¯¦t,§õ«ÛÀs,³¯Â×Þm,±i°ê®p,±iºû¦w,½²­^©ú,Áé¶¼¤å*,³¢¬fÅï* - - 1 - Oncotarget - Oncotarget 2017 8¨÷(62´Á):104831-54­¶
(IF: 5.168, »â°ì±Æ¦W: 44, »â°ì´Á¥Z¼Æ: 217, »â°ì±Æ¦W: 20.28%)

Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis.
Ya-Ling Hsu, Jen-Yu Hung, Yen-Lung Lee, Feng-Wei Chen, Kuo-Feng Chang, Wei-An Chang, Ying-Ming Tsai, Inn-Wen Chong*, Po-Lin Kuo* - - 1 - Oncotarget - Oncotarget 2017;8(62):104831-54
(IF: 5.168, Journal Ranking: 44, Number of Journals of this Field: 217, Ranking: 20.28%)

36

The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
·¨§Ó¤¯, ½²©ú¾§, ¬x¤¯¦t, §õª´¸©, ½²­^©ú, ½²·¶¯u, ³\·ç®p, ¼B¤j´¼, ¶À©ú½å, Áé¶¼¤å* - - 1 - BMC Pharmacology & Toxicology - BMC Pharmacol Toxicol 2017 18¨÷(1´Á):82­¶
(IF: 2.288, »â°ì±Æ¦W: 141, »â°ì´Á¥Z¼Æ: 257, »â°ì±Æ¦W: 54.86%)

The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
Yang CJ, Tsai MJ, Hung JY, Lee MH, Tsai YM, Tsai YC, Hsu JF, Liu TC, Huang MS, Chong IW* - - 1 - BMC Pharmacology & Toxicology - BMC Pharmacol Toxicol 2017;18(1):82
(IF: 2.288, Journal Ranking: 141, Number of Journals of this Field: 257, Ranking: 54.86%)

37

Laricitrin suppresses increased benzo(a)pyrene-induced, lung tumor-associated monocyte-derived dendritic cell cancer progression.
±iºû¦w,¬x¤¯¦t(¦@¦P²Ä¤@),½²­^©ú,³\¶®¬Â,«¸§»¿³,©P¥@µØ,¶À©ú½å*,³¢¬fÅï* - - 1 - Oncology Letters - ONCOL LETT 2016 11¨÷(3´Á):1783-1790­¶
(IF: 1.482, »â°ì±Æ¦W: 181, »â°ì´Á¥Z¼Æ: 213, »â°ì±Æ¦W: 84.98%)

Laricitrin suppresses increased benzo(a)pyrene-induced, lung tumor-associated monocyte-derived dendritic cell cancer progression.
Chang WA, Hung JY, Tsai YM, Hsu YL, Chiang HH, Chou SH, Huang MS, Kuo PL. - - 1 - Oncology Letters - ONCOL LETT 2016;11(3):1783-1790
(IF: 1.482, Journal Ranking: 181, Number of Journals of this Field: 213, Ranking: 84.98%)

38

Poorer prognosis in Taiwanese female ever smokers with stage iV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
·¨§Ó¤¯,½²©ú¾§,¬x¤¯¦t,½²­^©ú,§õ·ç·ë,©P¥@µØ,¼B¤j´¼,¨Hª´¬î,¶À©ú½å*,Áé¶¼¤å* - - 1 - OncoTargets and Therapy - ONCOTARGETS THER 2016 9¨÷(-´Á):1511-1518­¶
(IF: 2.272, »â°ì±Æ¦W: 70, »â°ì´Á¥Z¼Æ: 161, »â°ì±Æ¦W: 43.48%)

Poorer prognosis in Taiwanese female ever smokers with stage iV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
chih-Jen Yang, Ming-Ju Tsai, Jen-Yu hung, Ying-Ming Tsai, Jui-Ying lee, shahhwa chou,Ta-chih liu, Mei-chiou shen, Ming-shyan huang, inn-Wen chong - - 1 - OncoTargets and Therapy - ONCOTARGETS THER 2016;9(-):1511-1518
(IF: 2.272, Journal Ranking: 70, Number of Journals of this Field: 161, Ranking: 43.48%)

39

Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
³\¶®¬Â,¬x¤¯¦t,«¸ÄÉ©É,²²QªÚ,§d¬F¿o,ªL¨Ì«Å,½²­^©ú,©P¥@µØ,½²©ú¾§,³¢¬fÅï* - - 1 - Oncotarget - ONCOTARGET 2016 7¨÷(19´Á):27584-27598­¶
(IF: 5.008, »â°ì±Æ¦W: 36, »â°ì´Á¥Z¼Æ: 213, »â°ì±Æ¦W: 16.90%)

Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
Hsu YL, Hung JY, Chiang SY, Jian SF, Wu CY, Lin YS, Tsai YM, Chou SH, Tsai MJ, Kuo PL# - - 1 - Oncotarget - ONCOTARGET 2016;7(19):27584-27598
(IF: 5.008, Journal Ranking: 36, Number of Journals of this Field: 213, Ranking: 16.90%)

40

Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment.
·¨§Ó¤¯,½²©ú¾§,¬x¤¯¦t,§d¼e¿C,¼B¤j´¼,©P¥@µØ,§õ·ç­^,³\·çª@,½²­^©ú,¶À©ú½å,Áé¶¼¤å* - - 1 - OncoTargets and Therapy - ONCOTARGETS THER 2016 9¨÷(-´Á):1959-2587­¶
(IF: 2.272, »â°ì±Æ¦W: 70, »â°ì´Á¥Z¼Æ: 161, »â°ì±Æ¦W: 43.48%)

Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment.
4. Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, Kuan-Li Wu, Ta-Chih Liu, Shah-Hwa Chou, Jui-Ying Lee, Jui-Sheng Hsu, Ying-Ming Tsai1, Ming-Shyan Huang ,Inn-Wen Chong* - - 1 - OncoTargets and Therapy - ONCOTARGETS THER 2016;9(-):1959-2587
(IF: 2.272, Journal Ranking: 70, Number of Journals of this Field: 161, Ranking: 43.48%)

41

An Underestimated Co-infection: Swine Influenza and Pneumonia Due to Legionella pneumophila.
ªL©|»ö,³¯«Û¦°,¿c¬f¼Ù,½²­^©ú,³¯±¬ªN* - - 1 - american journal of the medical sciences - Am J Med Sci. 2016 352¨÷(3´Á):314-6­¶
(IF: 1.575, »â°ì±Æ¦W: 62, »â°ì´Á¥Z¼Æ: 155, »â°ì±Æ¦W: 40.00%)

An Underestimated Co-infection: Swine Influenza and Pneumonia Due to Legionella pneumophila.
Lin SY, Chen YH, Lu PL, Tsai YM, Chen TC* - - 1 - american journal of the medical sciences - Am J Med Sci. 2016;352(3):314-6
(IF: 1.575, Journal Ranking: 62, Number of Journals of this Field: 155, Ranking: 40.00%)

42

Acute respiratory distress syndrome and acute myocarditis developed in a previously healthy adult with influenza B.
±i¦°¨}, ³\·ç®p, ½²­^©ú, ªL©|»ö, ³¢¬¯§·, ·¨§Ó¤¯* - - 1 - BMC Pulmonary Medicine - BMC Pulm Med 2016 16¨÷(1´Á):1-5­¶
(IF: 2.329, »â°ì±Æ¦W: 30, »â°ì´Á¥Z¼Æ: 58, »â°ì±Æ¦W: 51.72%)

Acute respiratory distress syndrome and acute myocarditis developed in a previously healthy adult with influenza B.
Chang HL, Hsu JF, Tsai YM, Lin SY, Kuo HF, Yang CJ - - 1 - BMC Pulmonary Medicine - BMC Pulm Med 2016;16(1):1-5
(IF: 2.329, Journal Ranking: 30, Number of Journals of this Field: 58, Ranking: 51.72%)

43

6-Shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CCL2 in tumor-associated dendritic cells.
³\¶®¬Â, ¬x¤¯¦t, ½²­^©ú, ½²­^¬ü, ¶À©ú½å, «J©ú¾W, ³¢¬fÅï* - - 1 - JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY - J AGR FOOD CHEM 2015 63¨÷(6´Á):1730-1738­¶
(IF: 2.912, »â°ì±Æ¦W: 2, »â°ì´Á¥Z¼Æ: 56, »â°ì±Æ¦W: 3.57%)

6-Shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CCL2 in tumor-associated dendritic cells.
Hsu YL, Hung JY, Tsai YM, Tsai EM, Huang MS, Hou MF, Kuo PL. - - 1 - JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY - J AGR FOOD CHEM 2015;63(6):1730-1738
(IF: 2.912, Journal Ranking: 2, Number of Journals of this Field: 56, Ranking: 3.57%)

44

LIGHT Is a Crucial Mediator of Airway Remodeling
¬x¤¯¦t,½±¤h¤¯,½²©ú¾§,½²­^©ú,Áé¶¼¤å,Á«T©ú,³\¶®¬Â* - - 1 - JOURNAL OF CELLULAR PHYSIOLOGY - J CELL PHYSIOL 2015 230¨÷(5´Á):1042-1053­¶
(IF: 3.839, »â°ì±Æ¦W: 15, »â°ì´Á¥Z¼Æ: 83, »â°ì±Æ¦W: 18.07%)

LIGHT Is a Crucial Mediator of Airway Remodeling
Hung JY, Chiang SR, Tsai MJ, Tsai YM, Chong IW, Shieh JM, Hsu YL. - - 1 - JOURNAL OF CELLULAR PHYSIOLOGY - J CELL PHYSIOL 2015;230(5):1042-1053
(IF: 3.839, Journal Ranking: 15, Number of Journals of this Field: 83, Ranking: 18.07%)

45

Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis.
¬x¤¯¦t,±iºû¦w,½²­^©ú,³\¶®¬Â,«¸§»¿³,©P¥@µØ,¶À©ú½å*,³¢¬fÅï* - - 1 - INTERNATIONAL JOURNAL OF ONCOLOGY - INT J ONCOL 2015 46¨÷(5´Á):1985-1993­¶
(IF: 3.025, »â°ì±Æ¦W: 96, »â°ì´Á¥Z¼Æ: 211, »â°ì±Æ¦W: 45.50%)

Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis.
Hung JY, Chang WA, Tsai YM, Hsu YL, Chiang HH, Chou SH, Huang MS, Kuo PL - - 1 - INTERNATIONAL JOURNAL OF ONCOLOGY - INT J ONCOL 2015;46(5):1985-1993
(IF: 3.025, Journal Ranking: 96, Number of Journals of this Field: 211, Ranking: 45.50%)

46

Syringetin suppress osteoclastogenesis mediated by osteoblasts in human lung adenocarcinoma
½²­^©ú, Áé¶¼¤å, ¬x¤¯¦t, ±iºû¦w, ³¢¬fÅï, ½²©ú¾§, ³\¶®¬Â* - - 1 - ONCOLOGY REPORTS - ONCOL REP 2015 34¨÷(5´Á):617-626­¶
(IF: 2.301, »â°ì±Æ¦W: 138, »â°ì´Á¥Z¼Æ: 211, »â°ì±Æ¦W: 65.40%)

Syringetin suppress osteoclastogenesis mediated by osteoblasts in human lung adenocarcinoma
Ying-Ming Tsai, Inn-Wen Chong, Jen-Yu Hung, Wei-An Chang, Po-Lin Kuo, Ming-Ju Tsai, Ya-Ling Hsu* - - 1 - ONCOLOGY REPORTS - ONCOL REP 2015;34(5):617-626
(IF: 2.301, Journal Ranking: 138, Number of Journals of this Field: 211, Ranking: 65.40%)

47

Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli
³\·ç®p, ±i¦°¨}(¦@¦P²Ä¤@), ½²©ú¾§, ½²­^©ú, §õ«ÛÀs, ³¯°ö®Ù,­S¤å³Ç, Ĭ¨|¥¿, ·¨§Ó¤¯* - - 1 - World Journal of Surgical Oncology - WORLD J SURG ONCOL 2015 13¨÷(-´Á):288­¶
(IF: 1.408, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 198, »â°ì±Æ¦W: 54.04%)

Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli
Hsu, Jui-Feng; Chang, Hsu-Liang; Tsai, Ming-Ju; Tsai, Ying-Ming; Lee, Yen-Lung; Chen, Pei-Huan; Fan, Wen-Chieh; Su, Yu-Chung; Yang, Chih-Jen* - - 1 - World Journal of Surgical Oncology - WORLD J SURG ONCOL 2015;13(-):288
(IF: 1.408, Journal Ranking: 107, Number of Journals of this Field: 198, Ranking: 54.04%)

48

The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma.
·¨§Ó¤¯*,½²­^©ú(¦@¦P²Ä¤@),½²©ú¾§,±i¦°¨},¶À©ú½å - - 1 - CANCER CHEMOTHERAPY AND PHARMACOLOGY - CANCER CHEMOTH 2014 73¨÷(1´Á):199-205­¶
(IF: 2.571, »â°ì±Æ¦W: 107, »â°ì´Á¥Z¼Æ: 256, »â°ì±Æ¦W: 41.80%)

The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma.
Yang CJ*, Tsai YM, Tsai MJ, Chang HL, Huang MS - - 1 - CANCER CHEMOTHERAPY AND PHARMACOLOGY - CANCER CHEMOTH 2014;73(1):199-205
(IF: 2.571, Journal Ranking: 107, Number of Journals of this Field: 256, Ranking: 41.80%)

49

«e¦CÀô¯ÀÃþºcª«¹ï¸g¥ÑIP¨ü¾¹¤ÎcAMP¹ï³æ®Ö²y²Ó­M¤§¥¨¾½²Ó­Mµoª¢³J¥Õ-1£\¤§½Õ¸`
½²©ú³Í,Á¬³¬L(¦@¦P²Ä¤@),³¢¬¯§·,·¨¥ÍÙõ,³¢Îë§»,¶À盿»ö,½²­^©ú,§õ±Ó¥Í(¦@¦P²Ä¤@),¬x§Ó¿³* - - 1 - JOURNAL OF INVESTIGATIVE MEDICINE - J INVEST MED 2014 62¨÷(2´Á):332-339­¶
(IF: 1.503, »â°ì±Æ¦W: 70, »â°ì´Á¥Z¼Æ: 156, »â°ì±Æ¦W: 44.87%)

Effect of prostaglandin I2 analogs on macrophage inflammatory protein-1£\ in human monocytes via I prostanoid receptor and cyclic adenosine monophosphate
Ming-Kai Tsai, Chong-Chao Hsieh, Hsuan-Fu Kuo, San-Nan Yang, Chang-Hung Kuo, Ming-Yii Huang, Ying-Ming Tsai, Min-Sheng Lee, Chih-Hsing Hung* - - 1 - JOURNAL OF INVESTIGATIVE MEDICINE - J INVEST MED 2014;62(2):332-339
(IF: 1.503, Journal Ranking: 70, Number of Journals of this Field: 156, Ranking: 44.87%)

50

CD45¬¡¤Æ¦bIL-10¨Ì¿à¸~½F¦ñÀH¾ð¬ð²Ó­M¤À¤Æ§êºtÃöÁ䨤¦â
¾G¹F®¦,½²­^©ú(¦@¦P²Ä¤@),³\¶®¬Â,«J©ú¾W,½²­^¬ü,¤ý·Ó¤¸,¥Ì»T·ì,³¢¬fÅï* - - 1 - Oncology Letters - ONCOL LETT 2014 8¨÷(2´Á):620-626­¶
(IF: 0.987, »â°ì±Æ¦W: 183, »â°ì´Á¥Z¼Æ: 203, »â°ì±Æ¦W: 90.15%)

Cluster of differentiation 45 activation is crucial in interleukin 10 dependent tumor associated dendritic cell differentiation
Cheng DE, Tsai YM, Hsu YL, Hou MF, Tsai EM, Wang JY, Kan JY, Kuo PL - - 1 - Oncology Letters - ONCOL LETT 2014;8(2):620-626
(IF: 0.987, Journal Ranking: 183, Number of Journals of this Field: 203, Ranking: 90.15%)

51

Risk factors for venous port migration in a single institute in Taiwan
­S¤å³Ç, Wu CH(¦@¦P²Ä¤@), ½²©ú¾§, ½²­^©ú,±i¦°¨} , ¬x¤¯¦t, Chen PH, ·¨§Ó¤¯* - - 1 - World Journal of Surgical Oncology - World J Surg Oncol 2014 12¨÷(-´Á):15­¶
(IF: 1.2, »â°ì±Æ¦W: 121, »â°ì´Á¥Z¼Æ: 204, »â°ì±Æ¦W: 59.31%)

Risk factors for venous port migration in a single institute in Taiwan
Fan WC, Wu CH, Tsai MJ, Tsai YM, Chang HL, Hung JY, Chen PH, Yang CJ - - 1 - World Journal of Surgical Oncology - World J Surg Oncol 2014;12(-):15
(IF: 1.2, Journal Ranking: 121, Number of Journals of this Field: 204, Ranking: 59.31%)

52

The impact of inappropriate antibiotics on bacteremia patients in a community hospital in Taiwan: an emphasis on the impact of referral information for cases from a hospital affiliated nursing home
·¨§Ó¤¯,ÄÁ®Kãg(¦@¦P²Ä¤@), ³¯±¬ªN,±i¦°¨},½²­^©ú,¶À©ú½å, ³¯«Û¦°, ¿c¬f¼Ù* - - 1 - BMC INFECTIOUS DISEASES - BMC INFECT DIS 2013 13¨÷(-´Á):500(1-8)­¶
(IF: 3.025, »â°ì±Æ¦W: 24, »â°ì´Á¥Z¼Æ: 70, »â°ì±Æ¦W: 34.29%)

The impact of inappropriate antibiotics on bacteremia patients in a community hospital in Taiwan: an emphasis on the impact of referral information for cases from a hospital affiliated nursing home
Yang CJ, Chung YC, Chen TC, Chang HL, Tsai YM, Huang MS, Chen YH, Lu PL* - - 1 - BMC INFECTIOUS DISEASES - BMC INFECT DIS 2013;13(-):500(1-8)
(IF: 3.025, Journal Ranking: 24, Number of Journals of this Field: 70, Ranking: 34.29%)

53

Functional interaction of cockroach allergens and mannose receptor (CD206) in human circulating fibrocytes
½²­^©ú,Hsu SC, Zhang J, Zhou YF, Plunkett B, Huang SK, Gao PS - - 1 - PLOS ONE - PLoS One 2013 8¨÷(5´Á):e64105­¶
(IF: 3.73, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 56, »â°ì±Æ¦W: 12.50%)

Functional interaction of cockroach allergens and mannose receptor (CD206) in human circulating fibrocytes
Tsai YM, Hsu SC, Zhang J, Zhou YF, Plunkett B, Huang SK, Gao PS - - 1 - PLOS ONE - PLoS One 2013;8(5):e64105
(IF: 3.73, Journal Ranking: 7, Number of Journals of this Field: 56, Ranking: 12.50%)

54

Aryl hydrocarbon receptor controls murine mast cell homeostasis
Zhou Y, Tung HY, ½²­^©ú, Hsu SC, Chang HW, Kawasaki H, Tseng HC, Plunkett B, Gao P, Hung CH, Vonakis BM, Huang SK - - 1 - BLOOD - BLOOD 2013 121¨÷(16´Á):3195-3204­¶
(IF: 9.06, »â°ì±Æ¦W: 3, »â°ì´Á¥Z¼Æ: 67, »â°ì±Æ¦W: 4.48%)

Aryl hydrocarbon receptor controls murine mast cell homeostasis
Zhou Y, Tung HY, Tsai YM, Hsu SC, Chang HW, Kawasaki H, Tseng HC, Plunkett B, Gao P, Hung CH, Vonakis BM, Huang SK - - 1 - BLOOD - BLOOD 2013;121(16):3195-3204
(IF: 9.06, Journal Ranking: 3, Number of Journals of this Field: 67, Ranking: 4.48%)

55

ªÍÀù­l¥Í¥b¨Å¿}¾®¶°¯À-1³z¹LId3/IL-10°T®§³~®|»¤¾É¾ð¬ð²Ó­M¥¢¯à
³¢¬fÅï,¬x¤¯¦t,¶À¼S¨¦,©P¥@µØ,¾G¹F®¦,ÄÁ¨|§Ó,¬x§Ó¿³,·¨§Ó¤¯,½²­^©ú,³\¶®¬Â,¶À©ú½å* - - 1 - The Journal of Immunology - J IMMUNOL 2011 186¨÷(3´Á):1521-1530­¶
(IF: 5.745, »â°ì±Æ¦W: 20, »â°ì´Á¥Z¼Æ: 134, »â°ì±Æ¦W: 14.93%)

Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.
Po-Lin Kuo, Jen-Yu Hung, Shau-Ku Huang, Shah-Hwa Chou, Da-En Cheng, Yuh-Jyh Jong, Chih-Hsing Hung, Chih-Jen Yang, Ying-Ming Tsai, Ya-Ling Hsu, Ming-Shyan Huang* - - 1 - The Journal of Immunology - J IMMUNOL 2011;186(3):1521-1530
(IF: 5.745, Journal Ranking: 20, Number of Journals of this Field: 134, Ranking: 14.93%)

56

¤G²§Ùæ»Ä²§¦òº¸à¬¤ÏÀ³¤§IL-8¦b©I§l¹D¥­·Æ¦Ù²Ó­Mªº°T®§³~®|
³¢¬fÅï, ¶À©ú½å, ¶À¼S¨¦, ­Ù¶²¬î, ¬x¤¯¦t, ¸¯À³´Ü, ¬x§Ó¿³, ½²­^©ú, §ùªöæY, ³\¶®¬Â* - - 1 - European respiratory journal - EUR RESPIR J 2011 37¨÷(5´Á):1226-36­¶
(IF: 5.922, »â°ì±Æ¦W: 4, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 8.70%)

Signalling pathway of isophorone diisocyanate-responsive IL-8 in airway smooth muscle cells.
Po-Lin Kuo, Ming-Shyan Huang, Shau-Ku Huang, Wen-Chiu Ni, Jen-Yu Hung, Ying-Chin Ko, Chih-Hsing Hung, Ying-Ming Tsai, Tsai-Hui Duh, Ya-Ling Hsu* - - 1 - European respiratory journal - EUR RESPIR J 2011;37(5):1226-36
(IF: 5.922, Journal Ranking: 4, Number of Journals of this Field: 46, Ranking: 8.70%)

57

¥ú¥Ì¯ó©w³z¹LªýÂ_FAK/Rho°T®§³~®|§í¨îªÍÀù²Ó­M²¾¦æ¡B«I¤J¡B¦åºÞ·s¥Í
½²­^©ú,·¨§Ó¤¯,³\¶®¬Â,§d¹aà±,½²伃ÔÐ,¬x¤¯¦t,³s±Ò±¬,¶À©ú½å,³¢¬fÅï* - - 1 - Integrative Cancer Therapies - INTEGR CANCER THER 2011 10¨÷(4´Á):341-349­¶
(IF: 1.716, »â°ì±Æ¦W: 7, »â°ì´Á¥Z¼Æ: 19, »â°ì±Æ¦W: 36.84%)

Glabridin inhibits migration, invasion and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting FAK/Rho signaling pathway.
Ying-Ming Tsai, Chih-Jen Yang, Ya-Ling Hsu, Ling-Yu Wu, Yu-Chieh Tsai, Jen-Yu Hung, Chi-Tun Lien, Ming-Shyan Huang, Po-Lin Kuo* - - 1 - Integrative Cancer Therapies - INTEGR CANCER THER 2011;10(4):341-349
(IF: 1.716, Journal Ranking: 7, Number of Journals of this Field: 19, Ranking: 36.84%)

58

¥h²B¤ì­»¤ºà­³z¹L®ñ¤Æ»P¤º½èºôÀ£¤O°T®§»¤¾É«D¤p²Ó­MªÍÀù²Ó­M­ä¤`
¬x¤¯¦t,³\¶®¬Â,­Ù¶²¬î,½²­^©ú,·¨§Ó¤¯,³¢¬fÅï*,¶À©ú½å* - - 1 - Lung Cancer - LUNG CANCER 2010 68¨÷(3´Á):355-65­¶
(IF: 3.356, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 23.91%)

Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lung cancer cells
Jen-Yu Hung, Ya-Ling Hsu, Wen-Chiu Ni, Ying-Ming Tsai, Chih-Jen Yang, Po-Lin Kuo*, Ming-Shyan Huang* - - 1 - Lung Cancer - LUNG CANCER 2010;68(3):355-65
(IF: 3.356, Journal Ranking: 11, Number of Journals of this Field: 46, Ranking: 23.91%)

59

­»¸Á¯ó苷¡A¼s¦s¬a¾ïÃþ¤ôªG¤§¶Àà¬苷¡A³z¹LFas/Fas ligand³~®|»¤¾É«D¤p²Ó­MªÍÀù²Ó­M­ä¤`
¬x¤¯¦t,³\¶®¬Â,¸¯À³´Ü,½²­^©ú,·¨§Ó¤¯,¶À©ú½å*,³¢¬fÅï* - - 1 - Lung Cancer - LUNG CANCER 2010 68¨÷(3´Á):366-74­¶
(IF: 3.356, »â°ì±Æ¦W: 11, »â°ì´Á¥Z¼Æ: 46, »â°ì±Æ¦W: 23.91%)

Didymin, a dietary flavonoid glycoside from citrus fruits, induces Fas-mediated apoptotic pathway in human non-small cell lung cancer cells in vitro and in vivo.
Jen-Yu Hung,Ya-Ling Hsu,Ying-Chin Ko,Ying-Ming Tsai,Chih-Jen Yang,Ming-Shyan Huang,Po-Lin Kuo* - - 1 - Lung Cancer - LUNG CANCER 2010;68(3):366-74
(IF: 3.356, Journal Ranking: 11, Number of Journals of this Field: 46, Ranking: 23.91%)

60

¨Ï¥Î¤ôªÍ¼ç¤ô«áªºªÍ­M¥X¦å¢w¢w¤@¯f¨Ò³ø§i
½²©ú¾§, ½²¦Ì¤s*, ½²­^©ú, ³s±Ò±¬, ¶À¦N§Ó, ¶À©ú½å - - 1 - Kaohsiung Journal of Medical Sciences - KAOHSIUNG J MED SCI 2010 26¨÷(7´Á):389­¶
(IF: 0.607, »â°ì±Æ¦W: 83, »â°ì´Á¥Z¼Æ: 92, »â°ì±Æ¦W: 90.22%)

Alveolar Hemorrhage after Scuba Diving ¡V a case report
Ming-Ju Tsai, Mee-Sun Tsai, Ying-Ming Tsai, Chi-Tun Lien, Jhi-Jhu Hwang, Ming-Shyan Huang - - 1 - Kaohsiung Journal of Medical Sciences - KAOHSIUNG J MED SCI 2010;26(7):389
(IF: 0.607, Journal Ranking: 83, Number of Journals of this Field: 92, Ranking: 90.22%)

61

Transperineal ultrasonography in the diagnosis of Fournier's gangrene
½²©ú¾§, ³s±Ò±¬, ±iºû¦w, ÃQ§B¾§, ÁÂÌÉ¿«, ½²­^©ú, ½²©¾ºa, ¶À©ú½å* - - 1 - Ultrasound in Obstetrics and Gynecology - ULTRASOUND OBST GYN 2010 36¨÷(3´Á):389­¶
(IF: 3.154, »â°ì±Æ¦W: 1, »â°ì´Á¥Z¼Æ: 28, »â°ì±Æ¦W: 3.57%)

Transperineal ultrasonography in the diagnosis of Fournier's gangrene
Ming-Ju Tsai, Chi-Tun Lien, Wei-An Chang, Po-Ju Wei, Min-Han Hsieh, Ying-Ming Tsai, Jong-Rung Tsai, Ming-Shyan Huang - - 1 - Ultrasound in Obstetrics and Gynecology - ULTRASOUND OBST GYN 2010;36(3):389
(IF: 3.154, Journal Ranking: 1, Number of Journals of this Field: 28, Ranking: 3.57%)

62

¤@¦ì¥½´ÁµÇ°IºÜ¦å²G³zªR¯f±w¦P®É¦X¨Ö·P¬V«I¤J©ÊªÍÄTµß¯f¤Î¬¡°Ê©Êµ²®Ö¯f
§d¤j½n,·¨§Ó¤¯,½²­^©ú,¶À¦N§Ó,¶À©ú½å,¤ýªF¿Å* - - 9 - Thoracic Medicine - 2010 25¨÷(5´Á):238-244­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Coexisting Invasive Pulmonary Aspergillosis and Active Tuberculosis in a Patient with End-stage Renal Disease
Da-Wei Wu, Chih-Jen Yang; Ying-Ming Tsai, Jhi-Jhu Huang; Ming-Shyan Huang, Tung-Heng Wang - - 9 - Thoracic Medicine - 2010;25(5):238-244
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

63

Chronic kidney disease is a potential risk factor for the development of purple urine bag syndrome.
·¨§Ó¤¯,¿c¬f¼Ù,³¯±¬ªN,½²­^©ú,³s±Ò±¬,Áé¶¼¤å,¶À©ú½å - - 1 - J Am Geriatr Soc - 2009 57¨÷(40´Á):1937-1938­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Chronic kidney disease is a potential risk factor for the development of purple urine bag syndrome.
Yang CJ, Lu PL, Chen TC, Tasi YM, Lien CT, Chong IW, Huang MS - - 1 - J Am Geriatr Soc - 2009;57(40):1937-1938
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

64

Purple urine bag syndrome, not always a benign process.
·¨§Ó¤¯,½²­^©ú,¶À©ú½å*,Shih-Meng Yeh,¼B®a¾s - - 1 - Am J Emerg Med - 2009 27¨÷(7´Á):895-897­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Purple urine bag syndrome, not always a benign process.
Tasi YM, Huang MS*, Yang CJ, Yeh SM, Liu CC - - 1 - Am J Emerg Med - 2009;27(7):895-897
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

65

Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells
¬x¤¯¦t,·¨§Ó¤¯,½²­^©ú,¶À¥°¤å,¶À©ú½å - - 1 - Clin Exp Pharmacol Physiol - 2008 35¨÷(9´Á):995-1001­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells
Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS - - 1 - Clin Exp Pharmacol Physiol - 2008;35(9):995-1001
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

66

­ìµo©ÊªÍ´c©Ê²O¤Ú½F¡Ð²O¤Ú¼ß²Ó­M´c©Ê²O¤Ú½F¡G¯f¨Ò³ø§i¤Î¤åÄm¦^ÅU
½²­^©ú,¶À©ú½å,½²©¾ºa,Ĭ¤ë¬î,¼B¯q©÷,¶À¦N§Ó* - - 0 - ¯ÝµÄÂå¾Ç - 2008 23¨÷(2´Á):95-102­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Primary Pulmonary Lymphoma-Lymphoplasmacytic Lymphoma: A Case Report and Literature Review
Ying-Ming Tsai, Ming-Shyan Huang, Jong-Rung Tsai, Yue-Chiu Su, Yi-Chang Liu, Jhi-Jhu Hwang - - 0 - ¯ÝµÄÂå¾Ç - 2008;23(2):95-102
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

67

Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.
¬x¤¯¦t,·¨§Ó¤¯,½²­^©ú,¶À¥°¤å,¶À©ú½å - - 1 - Clin Exp Pharmacol Physiol - 2008 35¨÷(2´Á):141-147­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.
Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS. - - 1 - Clin Exp Pharmacol Physiol - 2008;35(2):141-147
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

68

Re: An occult foreign body aspiration with bronchial anomaly mimicking asthma and pneumonia
·¨§Ó¤¯,½²­^©ú,¤ý¶Ç¥Í,¶À©ú½å - - 1 - Dent Traumatol - 2008 24¨÷(5´Á):593-594­¶
(IF: 0, »â°ì±Æ¦W: 0, »â°ì´Á¥Z¼Æ: 0, »â°ì±Æ¦W: -%)

Re: An occult foreign body aspiration with bronchial anomaly mimicking asthma and pneumonia
Chih-Jen Yang, Ying-Ming Tsai, Chuan-Sheng Wang, Ming-Shyab Huang. - - 1 - Dent Traumatol - 2008;24(5):593-594
(IF: 0, Journal Ranking: 0, Number of Journals of this Field: 0, Ranking: -%)

69

Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.
¬x¤¯¦t,·¨§Ó¤¯, ½²­^©ú, ¶À¥°¤å, ¶À©ú½å* - - 1 - Clinical and Experimental Pharmacology and Physiology - Clin Exp Pharmacol Physiol 2008 35¨÷(2´Á):141-147­¶
(IF: 2.038, »â°ì±Æ¦W: 117, »â°ì´Á¥Z¼Æ: 219, »â°ì±Æ¦W: 53.42%)

Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells.
Hung JY, Yang CJ, Tsai YM, Huang HW, Huang MS. - - 1 - Clinical and Experimental Pharmacology and Physiology - Clin Exp Pharmacol Physiol 2008;35(2):141-147
(IF: 2.038, Journal Ranking: 117, Number of Journals of this Field: 219, Ranking: 53.42%)

 Project

NO
YEAR ¡X Source ¡X No ¡X Type
Project Name
Duration
1
115 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC113-2314-B-037-098-MY3 ¡X 1 ­Ó¤H«¬
³æ²Ó­M¬ã¨s±´¯ÁªÍÀù¸£Âಾ¶i¶¥¤À¤lÂŹÏ(3/3)( )
2026/08/01 ~ 2027/07/31
2
114 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC112-2314-B-037-126-MY3 ¡X 1 ­Ó¤H«¬
¾ã¦XªÅ¶¡©M³æ²Ó­M¦hÅé¾Ç±´¯ÁªÎ­D¹ï®ð³Ý¼vÅT¤À¤lÂŹÏ(3/3)( )
2025/08/01 ~ 2026/07/31
3
114 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC113-2314-B-037-098-MY3 ¡X 1 ­Ó¤H«¬
³æ²Ó­M¬ã¨s±´¯ÁªÍÀù¸£Âಾ¶i¶¥¤À¤lÂŹÏ(2/3)( )
2025/08/01 ~ 2027/07/31
4
113 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC112-2314-B-037-126-MY3 ¡X 1 ­Ó¤H«¬
¾ã¦XªÅ¶¡©M³æ²Ó­M¦hÅé¾Ç±´¯ÁªÎ­D¹ï®ð³Ý¼vÅT¤À¤lÂŹÏ(2/3)( )
2024/08/01 ~ 2026/07/31
5
113 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC113-2314-B-037-098-MY3 ¡X 1 ­Ó¤H«¬
³æ²Ó­M¬ã¨s±´¯ÁªÍÀù¸£Âಾ¶i¶¥¤À¤lÂŹÏ(1/3)( )
2024/08/01 ~ 2027/07/31
6
112 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST110-2314-B-037-124-MY3 ¡X 1 ­Ó¤H«¬
§Q¥Î³æ²Ó­M°ò¦]©w§Ç±´°QªÍ¸¢Àù§K¬Ì²Ó­M²§½è©Ê¤Î¬ã¨s¨ä¥\¯à©Ê§ïÅÜ(3/3)( )
2023/08/01 ~ 2024/07/31
7
112 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X NSTC112-2314-B-037-126-MY3 ¡X 1 ­Ó¤H«¬
¾ã¦XªÅ¶¡©M³æ²Ó­M¦hÅé¾Ç±´¯ÁªÎ­D¹ï®ð³Ý¼vÅT¤À¤lÂŹÏ(1/3)( )
2023/08/01 ~ 2026/07/31
8
111 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST110-2314-B-037-124-MY3 ¡X 1 ­Ó¤H«¬
§Q¥Î³æ²Ó­M°ò¦]©w§Ç±´°QªÍ¸¢Àù§K¬Ì²Ó­M²§½è©Ê¤Î¬ã¨s¨ä¥\¯à©Ê§ïÅÜ(2/3)( )
2022/08/01 ~ 2024/07/31
9
110 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST110-2314-B-037-124-MY3 ¡X 1 ­Ó¤H«¬
§Q¥Î³æ²Ó­M°ò¦]©w§Ç±´°QªÍ¸¢Àù§K¬Ì²Ó­M²§½è©Ê¤Î¬ã¨s¨ä¥\¯à©Ê§ïÅÜ(1/3)( )
2021/08/01 ~ 2024/07/31
10
109 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST109-2314-B-037-091 ¡X 1 ­Ó¤H«¬
±´°QªÍÀùÂಾ¤§¿Ë¸£ÁͩʩMªvÀø¶}µo¬ã¨s( )
2020/08/01 ~ 2021/07/31
11
108 ¡X N °ê¬ì·|(­ì¬ì§Þ³¡) ¡X MOST108-2314-B-037-095 ¡X 1 ­Ó¤H«¬
ªÍÀù¤Î¨ä¦Ø½¤Âಾ¤§¾÷¨î±´°Q( )
2019/08/01 ~ 2020/07/31
12
107 ¡X Q ·s¸u±Ð®v­pµe(®Õ¤º) ¡X KMU-Q108006 ¡X  
ªÍÀù¤Î¨ä¦Ø½¤Âಾ¤§¾÷¨î±´°Q( )
2019/01/01 ~ 2019/12/31

 Patent